Chlorion Pharma Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Out of Business

  • Employees
  • 11

Employees

  • Latest Deal Type
  • Out of Business

Chlorion Pharma General Information

Description

Provider of therapeutics designed to treat neuropathic pain and epilepsy. The company's therapeutics quell neuronal hyperactivity by correct aberrant chloride homeostasis, enabling patients to get cured from neuropathic diseases.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 500 Cartier Boulevard West
  • Suite 132
  • Laval, Quebec H7V 2B7
  • Canada
+1 (450)
Primary Industry
Biotechnology
Other Industries
Drug Delivery
Drug Discovery
Vertical(s)
Corporate Office
  • 500 Cartier Boulevard West
  • Suite 132
  • Laval, Quebec H7V 2B7
  • Canada
+1 (450)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Chlorion Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 01-Jan-2011 Completed Out of Business
4. Grant 03-Jun-2009 Completed Startup
3. Early Stage VC 15-Dec-2008 Completed Startup
2. Early Stage VC (Series A) 15-Oct-2007 $6.01M $6.01M Completed Startup
1. Seed Round Completed Startup
To view Chlorion Pharma’s complete valuation and funding history, request access »

Chlorion Pharma Patents

Chlorion Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2010132999-A1 Methyl sulfanyl pyrmidmes useful as antiinflammatories, analgesics, and antiepileptics Inactive 21-May-2009
WO-2010132999-A8 Methyl sulfanyl pyrmidmes useful as antiinflammatories, analgesics, and antiepileptics Inactive 21-May-2009
AU-2009225984-A1 Substituted pyrrolidine and piperidine compounds, derivatives thereof, and methods for treating pain Inactive 21-Mar-2008
CA-2718959-A1 Substituted pyrrolidine and piperidine compounds, derivatives thereof, and methods for treating pain Inactive 21-Mar-2008
EP-2268616-A1 Substituted pyrrolidine and piperidine compounds, derivatives thereof, and methods for treating pain Inactive 21-Mar-2008 C07D207/10
To view Chlorion Pharma’s complete patent history, request access »

Chlorion Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Chlorion Pharma FAQs

  • When was Chlorion Pharma founded?

    Chlorion Pharma was founded in 2004.

  • Where is Chlorion Pharma headquartered?

    Chlorion Pharma is headquartered in Laval, Canada.

  • What is the size of Chlorion Pharma?

    Chlorion Pharma has 11 total employees.

  • What industry is Chlorion Pharma in?

    Chlorion Pharma’s primary industry is Biotechnology.

  • Is Chlorion Pharma a private or public company?

    Chlorion Pharma is a Private company.

  • What is Chlorion Pharma’s current revenue?

    The current revenue for Chlorion Pharma is .

  • How much funding has Chlorion Pharma raised over time?

    Chlorion Pharma has raised $10M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process